Overview: FDA recalls prazosin hydrochloride amid carcinogen concerns The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of more than half a million bottles of the blood pressure medication prazosin hydrochloride. The recall stems from concerns that the drug may contain a cancer-causing chemical. The affected lots were distributed by Teva Pharmaceutical…